A federal judge unexpectedly rescinded an order dismissing Mylan Laboratories Inc. from a class action lawsuit, leaving the pharmaceuticals company a bit unsure of where it stands. Mylan, based in Canonsburg, announced last week the judge had granted its unopposed motion to be dismissed from the lawsuit, filed in Massachusetts by several state regulators and other parties. The lawsuit in U.S. District Court in Boston alleges that Mylan and other pharmaceuticals companies improperly reported "average wholesale price" information about generic drugs, leading agencies to overpay for the medicines.
Posted by Editor at October 13, 2003 10:12 AM